White Paper

The Golden Retriever Lifetime Study: 5 Years Of Progress In Veterinary Health And Biobanking

By Sharon Albright, DVM

Scientist

Cancer is the leading cause of death in dogs over the age of two, and Golden Retrievers (GRs) are at high risk of cancer development. Morris Animal Foundation wishes to better define the incidence and risk factors for cancer in GRs enrolled in this cohort and assess the risk factors for other major medical conditions, diseases and disorders in GRs enrolled in this cohort by conducting a prospective lifetime cohort study.

The Golden Retriever Lifetime Study is a  prospective cohort study of approximately 3,000 GRs under the age of 2 years at enrollment with subsequent annual health exams, laboratory tests, questionnaire responses, and sample collection for archival storage. Dogs will be followed from the time of enrollment until death.

An objective of this study is to establish extensive data and biological sample repositories for future analyses of major diseases, disorders or conditions in Golden Retrievers.

VIEW THE WHITE PAPER!
Signing up provides unlimited access to:
Signing up provides unlimited access to:
  • Trend and Leadership Articles
  • Case Studies
  • Extensive Product Database
  • Premium Content
HELLO. PLEASE LOG IN. X

Not yet a member of Outsourced Pharma? Register today.

ACCOUNT SIGN UP X
Please fill in your account details
Login Information
I'm interested in newsletter subscriptions.
ACCOUNT SIGN UP

Subscriptions

Sign up for the newsletter that brings you the industry's latest news, technologies, trends and products.

You might also want to: